Healthcare Billing Codes Search
Procedures
Specialties
Medicare
Hospitals
Categories
CPT Codes▼
HCPCS Codes▼
Ambulance and Other Transport Services and Supplies (A0021-A0999)
Matrix for Wound Management (Placental, Equine, Synthetic) (A2001-A2021)
Skin Substitute Device (A4100-A4100)
Medical And Surgical Supplies (A4206-A8004)
Administrative, Miscellaneous and Investigational (A9150-A9999)
Enteral and Parenteral Therapy (B4034-B9999)
Other Therapeutic Procedures (C1052-C1062)
Outpatient PPS (C1713-C9899)
Durable Medical Equipment (E0100-E8002)
Procedures / Professional Services (G0008-G9987)
Alcohol and Drug Abuse Treatment (H0001-H2037)
Drugs Administered Other than Oral Method (J0120-J8999)
Chemotherapy Drugs (J9000-J9999)
Durable medical equipment (DME) Medicare administrative contractors (MACs) (K0001-K0900)
Components, Accessories and Supplies (K1001-K1035)
Orthotic Procedures and services (L0112-L4631)
Prosthetic Procedures (L5000-L9900)
MIPS Value Pathways (M0001-M0005)
EOM (Enhancing Oncology Model) Enhanced Services (M0010-M0010)
Miscellaneous Medical Services (M0075-M0301)
Screening Procedures (M1003-M1070)
Episode of Care (M1106-M1143)
Other Services (M1146-M1210)
Pathology and Laboratory Services (P2028-P9615)
Temporary Codes (Q0035-Q9992)
Diagnostic Radiology Services (R0070-R0076)
Temporary National Codes (Non-Medicare) (S0012-S9999)
National Codes Established for State Medicaid Agencies (T1000-T5999)
Coronavirus Diagnostic Panel (U0001-U0005)
Vision Services (V2020-V2799)
Hearing Services (V5008-V5364)
MS-DRG Codes▼
RC Codes▼
APR-DRG Codes▼
Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior t...
Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months pri...
HER-2/neu positive
AJCC Stage at breast cancer diagnosis = II Or III
AJCC Stage at breast cancer diagnosis = I (Ia Or Ib) And t-Stage At breast cancer diagnosis does not...
Patient has metastatic disease at diagnosis
Anti-EGFR monoclonal antibody therapy
RAS (KRAS and NRAS) gene mutation testing performed before initiation of anti-EGFR moab
RAS (KRAS and NRAS) gene mutation testing not performed before initiation of anti-EGFR moab
Patient has metastatic disease at diagnosis
RAS (KRAS and NRAS) gene mutation
Patient did not receive Anti-EGFR monoclonal antibody therapy
Patient received Anti-EGFR monoclonal antibody therapy
Patients who died from cancer
Patient received systemic cancer-directed therapy in the last 14 days of life
Patient did not receive systemic cancer-directed therapy in the last 14 days of life
Patients who died from cancer
Patient admitted to the ICU in the last 30 days of life
Patient was not admitted to the ICU in the last 30 days of life
Patient enrolled in hospice